RVXCF - Resverlogix Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue4/30/20194/30/20184/30/20174/30/2016
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development32,23037,49229,75615,366
Selling General and Administrative6,5104,0704,2694,326
Non Recurring----
Others----
Total Operating Expenses38,74041,56234,02519,692
Operating Income or Loss-38,740-41,562-34,025-19,692
Income from Continuing Operations
Total Other Income/Expenses Net-124,029-16,701-12,102-12
Earnings Before Interest and Taxes-38,740-41,562-34,025-19,692
Interest Expense-5,632-5,066-7,034-6,189
Income Before Tax-162,769-58,263-46,127-19,704
Income Tax Expense29478311
Minority Interest----
Net Income From Continuing Ops-162,798-58,310-46,210-19,715
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-162,798-58,310-46,210-19,715
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-162,798-58,310-46,210-19,715